-
1
-
-
0031947875
-
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
-
M. Al-Sarraf, M. LeBlanc, and P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
-
(1998)
J Clin Oncol
, vol.16
, pp. 1310-1317
-
-
Al-Sarraf, M.1
Leblanc, M.2
Giri, P.G.3
-
2
-
-
0037441720
-
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
-
J.C. Lin, J.S. Jan, and C.Y. Hsu Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
-
(2003)
J Clin Oncol
, vol.21
, pp. 631-637
-
-
Lin, J.C.1
Jan, J.S.2
Hsu, C.Y.3
-
3
-
-
15944417086
-
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
-
A.T. Chan, S.F. Leong, and R.K. Ngan Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 2005 536 539
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 536-539
-
-
Chan, A.T.1
Leong, S.F.2
Ngan, R.K.3
-
4
-
-
27244452301
-
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
-
J. Wee, E.H. Tan, and B.C. Tai Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 2005 6730 6738
-
(2005)
J Clin Oncol
, vol.23
, pp. 6730-6738
-
-
Wee, J.1
Tan, E.H.2
Tai, B.C.3
-
5
-
-
0344915699
-
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. Radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA i trial
-
International Nasopharynx Cancer Study Group Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial Int J Radiat Oncol Biol Phys 35 1996 463 469
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.35
, pp. 463-469
-
-
-
6
-
-
15444347863
-
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group
-
D.T. Chua, J.S. Sham, and D. Choy Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group Cancer 83 1998 2270 2283
-
(1998)
Cancer
, vol.83
, pp. 2270-2283
-
-
Chua, D.T.1
Sham, J.S.2
Choy, D.3
-
7
-
-
0035282127
-
Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
-
J. Ma, H.Q. Mai, and M.H. Hong Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 1350 1357
-
(2001)
J Clin Oncol
, vol.19
, pp. 1350-1357
-
-
Ma, J.1
Mai, H.Q.2
Hong, M.H.3
-
8
-
-
0035576411
-
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
-
R.L. Hong, L.L. Ting, and J.Y. Ko Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 4305 4313
-
(2001)
J Clin Oncol
, vol.19
, pp. 4305-4313
-
-
Hong, R.L.1
Ting, L.L.2
Ko, J.Y.3
-
9
-
-
84856918008
-
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma
-
M. Komatsu, M. Tsukuda, and H. Matsuda Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma Anticancer Res 32 2012 681 686
-
(2012)
Anticancer Res
, vol.32
, pp. 681-686
-
-
Komatsu, M.1
Tsukuda, M.2
Matsuda, H.3
-
10
-
-
0034309182
-
Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
-
A.J. Davis, and J.F. Tannock Repopulation of tumour cells between cycles of chemotherapy: A neglected factor Lancet Oncol 1 2000 86 93
-
(2000)
Lancet Oncol
, vol.1
, pp. 86-93
-
-
Davis, A.J.1
Tannock, J.F.2
-
11
-
-
0028278817
-
Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer
-
J. Bourhis, G. Wilson, and P. Wibault Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer Laryngoscope 104 1994 468 472
-
(1994)
Laryngoscope
, vol.104
, pp. 468-472
-
-
Bourhis, J.1
Wilson, G.2
Wibault, P.3
-
12
-
-
66949122761
-
Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population
-
M. Airoldi, A.M. Gabriele, and M. Garzaro Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population Radiother Oncol 92 2009 105 110
-
(2009)
Radiother Oncol
, vol.92
, pp. 105-110
-
-
Airoldi, M.1
Gabriele, A.M.2
Garzaro, M.3
-
13
-
-
79955557725
-
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma
-
M. Airoldi, P. Gabriele, and A.M. Gabriele Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma Cancer Chemother Pharmacol 67 2011 1027 1034
-
(2011)
Cancer Chemother Pharmacol
, vol.67
, pp. 1027-1034
-
-
Airoldi, M.1
Gabriele, P.2
Gabriele, A.M.3
-
14
-
-
41749096627
-
Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
-
E. Mostafa, M.N. Nasar, and N.A. Rabie Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma J Egypt Natl Canc Inst 18 2006 348 356
-
(2006)
J Egypt Natl Canc Inst
, vol.18
, pp. 348-356
-
-
Mostafa, E.1
Nasar, M.N.2
Rabie, N.A.3
-
15
-
-
75549092146
-
Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
-
W.K. Bae, J.E. Hwang, and H.J. Shim Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer Cancer Chemother Pharmacol 65 2010 589 595
-
(2010)
Cancer Chemother Pharmacol
, vol.65
, pp. 589-595
-
-
Bae, W.K.1
Hwang, J.E.2
Shim, H.J.3
-
16
-
-
80155124275
-
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
-
P. Bossi, E. Orlandi, and C. Bergamini Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer Ann Oncol 22 2011 2495 2500
-
(2011)
Ann Oncol
, vol.22
, pp. 2495-2500
-
-
Bossi, P.1
Orlandi, E.2
Bergamini, C.3
-
17
-
-
58249089750
-
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma
-
E.P. Hui, B.B. Ma, and S.F. Leung Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 2009 242 249
-
(2009)
J Clin Oncol
, vol.27
, pp. 242-249
-
-
Hui, E.P.1
Ma, B.B.2
Leung, S.F.3
-
18
-
-
84856316834
-
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
-
G. Fountzilas, E. Ciuleanu, and M. Bobos Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation Ann Oncol 23 2012 427 435
-
(2012)
Ann Oncol
, vol.23
, pp. 427-435
-
-
Fountzilas, G.1
Ciuleanu, E.2
Bobos, M.3
-
19
-
-
27344447760
-
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
-
A.W. Lee, W.H. Lau, and S.Y. Tung Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 2005 6966 6975
-
(2005)
J Clin Oncol
, vol.23
, pp. 6966-6975
-
-
Lee, A.W.1
Lau, W.H.2
Tung, S.Y.3
-
20
-
-
33746799334
-
Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma
-
A.W. Lee, S.Y. Tung, and A.T. Chan Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 2006 142 151
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 142-151
-
-
Lee, A.W.1
Tung, S.Y.2
Chan, A.T.3
-
21
-
-
49449113097
-
4th FY Khoo Memorial lecture 2008. Nasopharyngeal Cancer Workgroup - The past, the present and the future
-
J. Wee 4th FY Khoo Memorial lecture 2008. Nasopharyngeal Cancer Workgroup - the past, the present and the future Ann Acad Med Singap 37 2008 606 614
-
(2008)
Ann Acad Med Singap
, vol.37
, pp. 606-614
-
-
Wee, J.1
-
22
-
-
0034895749
-
Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
-
M.J. Edelman, H. Quam, and B. Mullins Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines Cancer Chemother Pharmacol 48 2001 141 144
-
(2001)
Cancer Chemother Pharmacol
, vol.48
, pp. 141-144
-
-
Edelman, M.J.1
Quam, H.2
Mullins, B.3
-
23
-
-
19944433612
-
Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A Phase II trial using a triplet combination
-
S.S. Leong, J. Wee, and M.H. Tay Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A Phase II trial using a triplet combination Cancer 103 2005 569 575
-
(2005)
Cancer
, vol.103
, pp. 569-575
-
-
Leong, S.S.1
Wee, J.2
Tay, M.H.3
-
24
-
-
53149111132
-
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
-
S.S. Leong, J. Wee, and S. Rajan Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma Cancer 113 6 2008 Sep 15 1332 1337
-
(2008)
Cancer
, vol.113
, Issue.6
, pp. 1332-1337
-
-
Leong, S.S.1
Wee, J.2
Rajan, S.3
-
25
-
-
29244448683
-
Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients
-
B. Baujat, H. Audry, and J. Bourhis Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 47-56
-
-
Baujat, B.1
Audry, H.2
Bourhis, J.3
-
26
-
-
35548966042
-
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
-
J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
-
(2007)
N Engl J Med
, vol.357
, pp. 1695-1704
-
-
Vermorken, J.B.1
Remenar, E.2
Van Herpen, C.3
-
27
-
-
35548972994
-
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
-
M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
-
(2007)
N Engl J Med
, vol.357
, pp. 1705-1715
-
-
Posner, M.R.1
Hershock, D.M.2
Blajman, C.R.3
-
28
-
-
84925303617
-
Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer [abstract]
-
(suppl; abstr 6003
-
Terence Tan, Wan-Teck Lim, Kam-Weng Fong et al. Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer [abstract]. J Clin Oncol 32:5s, 2014 (suppl; abstr 6003)
-
(2014)
J Clin Oncol
, vol.32
, pp. 5s
-
-
Tan, T.1
Lim, W.2
Fong Et Al., K.3
-
29
-
-
0036569761
-
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience
-
N. Lee, P. Xia, and J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 12-22
-
-
Lee, N.1
Xia, P.2
Quivey, J.M.3
-
30
-
-
29244459121
-
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience
-
S.L. Wolden, W.C. Chen, and D.G. Pfister Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 2006 57 62
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 57-62
-
-
Wolden, S.L.1
Chen, W.C.2
Pfister, D.G.3
-
31
-
-
84867048784
-
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. Conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
-
G. Peng, T. Wang, and K.Y. Yang A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 2012 286 293
-
(2012)
Radiother Oncol
, vol.104
, pp. 286-293
-
-
Peng, G.1
Wang, T.2
Yang, K.Y.3
-
32
-
-
84890110008
-
Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma
-
P.Y. Ouyang, Z. Su, and Y.P. Mao Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 22 2013 2285 2294
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 2285-2294
-
-
Ouyang, P.Y.1
Su, Z.2
Mao, Y.P.3
-
33
-
-
0037669569
-
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
-
S.F. Leung, A.T. Chan, and B. Zee Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type Cancer 98 2003 288 291
-
(2003)
Cancer
, vol.98
, pp. 288-291
-
-
Leung, S.F.1
Chan, A.T.2
Zee, B.3
-
34
-
-
84906818712
-
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
-
E.E.W. Cohen, T.G. Karrison, and Kocherginsky Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer J Clin Oncol 32 2014 2735 2743
-
(2014)
J Clin Oncol
, vol.32
, pp. 2735-2743
-
-
Cohen, E.E.W.1
Karrison, T.G.2
Kocherginsky3
-
35
-
-
84875267472
-
Induction chemotherapy followed by concurrent chemotherapy (sequential chemotherapy) versus concurrent chemotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
-
R. Haddad, A. O'Neill, and G. Rabinowits Induction chemotherapy followed by concurrent chemotherapy (sequential chemotherapy) versus concurrent chemotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial Lancet Oncol 14 2013 257 264
-
(2013)
Lancet Oncol
, vol.14
, pp. 257-264
-
-
Haddad, R.1
O'Neill, A.2
Rabinowits, G.3
-
36
-
-
84899476710
-
A randomized phase III trial comparing induction chemotherapy followed by chemotherapy versus chemotherapy alone as treatment of unresectable head and neck cancer
-
R. Hitt, J.J. Grau, and A. Lopez-Pousa A randomized phase III trial comparing induction chemotherapy followed by chemotherapy versus chemotherapy alone as treatment of unresectable head and neck cancer Ann Oncol 25 2014 216 225
-
(2014)
Ann Oncol
, vol.25
, pp. 216-225
-
-
Hitt, R.1
Grau, J.J.2
Lopez-Pousa, A.3
-
37
-
-
84925302061
-
Plasma EBV DNA as a predictive biomarker in patients with endemic nasopharyngeal carcinoma treated with induction chemotherapy and concurrent chemoradiation therapy [abstract]
-
M. Chua, O. Whee Sze, and J. Wee Plasma EBV DNA as a predictive biomarker in patients with endemic nasopharyngeal carcinoma treated with induction chemotherapy and concurrent chemoradiation therapy [abstract] Int J Radiat Oncol Biol Phys 90 Suppl. 2014 S120 S121
-
(2014)
Int J Radiat Oncol Biol Phys
, vol.90
, pp. S120-S121
-
-
Chua, M.1
Whee Sze, O.2
Wee, J.3
-
38
-
-
4444256753
-
Another way to estimate outcome of advanced nasopharyngeal carcinoma - Is concurrent chemoradiotherapy adequate?
-
J.C. Lin, W.M. Liang, and J.S. Jan Another way to estimate outcome of advanced nasopharyngeal carcinoma - is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys 60 2004 156 164
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 156-164
-
-
Lin, J.C.1
Liang, W.M.2
Jan, J.S.3
|